{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:27:56Z","timestamp":1793413676008,"version":"4.5.0"},"reference-count":103,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/gme.0b013e3182960cf8","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T13:58:17Z","timestamp":1444744697000},"page":"695-709","source":"Crossref","is-referenced-by-count":225,"title":["Critical window hypothesis of hormone therapy and cognition"],"prefix":"10.1097","volume":"20","author":[{"given":"Pauline M.","family":"Maki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-16-20210211","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census.","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch Neurol"},{"key":"R3-16-20210211","first-page":"1","article-title":"Deaths: final data for 2005.","volume":"56","author":"Kung","year":"2008","journal-title":"CDC Natl Vital Stat Rep"},{"key":"R4-16-20210211","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1532-5415.2012.04056.x","article-title":"Burden of Alzheimers disease-related mortality in the United States, 1999-2008.","volume":"60","author":"Moschetti","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"R5-16-20210211","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1212\/WNL.53.9.1992","article-title":"Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM Incidence Research Group.","volume":"53","author":"Andersen","year":"1999","journal-title":"Neurology"},{"key":"R9-16-20210211","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Womens Health Initiative Memory Study.","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"key":"R10-16-20210211","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Womens Health Initiative Memory Study: a randomized controlled trial.","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"R11-16-20210211","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.410150406","article-title":"Alzheimers disease: a study of epidemiological aspects.","volume":"15","author":"Heyman","year":"1984","journal-title":"Ann Neurol"},{"key":"R12-16-20210211","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.36.7.922","article-title":"Risk factors for clinically diagnosed Alzheimers disease: a case-control study of an Italian population.","volume":"36","author":"Amaducci","year":"1986","journal-title":"Neurology"},{"key":"R13-16-20210211","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.40.11.1698","article-title":"A case-control study of Alzheimers disease in Australia.","volume":"40","author":"Broe","year":"1990","journal-title":"Neurology"},{"key":"R14-16-20210211","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.410280607","article-title":"A case-control study of Alzheimers disease.","volume":"28","author":"Graves","year":"1990","journal-title":"Ann Neurol"},{"key":"R15-16-20210211","first-page":"334","article-title":"Lack of postmenopausal estrogen replacement therapy and the risk of dementia.","volume":"7","author":"Mortel","year":"1994","journal-title":"J Neuropsychiatry"},{"key":"R16-16-20210211","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.50.4.996","article-title":"Estrogen-replacement therapy and Alzheimers disease in the Italian Longitudinal Study on Aging.","volume":"50","author":"Baldereschi","year":"1998","journal-title":"Neurology"},{"key":"R17-16-20210211","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1212\/WNL.52.3.551","article-title":"A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics.","volume":"52","author":"Harwood","year":"1999","journal-title":"Neurology"},{"key":"R18-16-20210211","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/jnnp.67.6.779","article-title":"Estrogen use and early onset Alzheimers disease: a population-based study.","volume":"67","author":"Slooter","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-16-20210211","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jnnp.2003.024927","article-title":"Postmenopausal hormone therapy and Alzheimers disease risk: interaction with age.","volume":"76","author":"Henderson","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R20-16-20210211","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/oxfordjournals.aje.a117245","article-title":"Postmenopausal estrogen replacement therapy and the risk of Alzheimers disease: a population-based case-control study.","volume":"140","author":"Brenner","year":"1994","journal-title":"Am J Epidemiol"},{"key":"R21-16-20210211","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archneur.1994.00540210068014","article-title":"Estrogen replacement therapy in older women. Comparisons between Alzheimers disease cases and nondemented control subjects.","volume":"51","author":"Henderson","year":"1994","journal-title":"Arch Neurol"},{"key":"R22-16-20210211","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1001\/archinte.1996.00440180075009","article-title":"Estrogen replacement therapy and risk of Alzheimer disease.","volume":"156","author":"Paganini-Hill","year":"1996","journal-title":"Arch Intern Med"},{"key":"R23-16-20210211","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1212\/WNL.52.5.965","article-title":"Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.","volume":"52","author":"Waring","year":"1999","journal-title":"Neurology"},{"key":"R24-16-20210211","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.58.3.435","article-title":"Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease.","volume":"58","author":"Seshadri","year":"2001","journal-title":"Arch Neurol"},{"key":"R25-16-20210211","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(96)03356-9","article-title":"Effect of oestrogen during menopause on risk and age at onset of Alzheimers disease.","volume":"348","author":"Tang","year":"1996","journal-title":"Lancet"},{"key":"R26-16-20210211","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.48.6.1517","article-title":"A prospective study of estrogen replacement therapy and the risk of developing Alzheimers disease: the Baltimore Longitudinal Study of Aging.","volume":"48","author":"Kawas","year":"1997","journal-title":"Neurology"},{"key":"R27-16-20210211","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","article-title":"Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.","volume":"288","author":"Zandi","year":"2002","journal-title":"JAMA"},{"key":"R28-16-20210211","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1212\/WNL.0b013e318271f823","article-title":"Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.","volume":"79","author":"Shao","year":"2012","journal-title":"Neurology"},{"key":"R29-16-20210211","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.279.9.688","article-title":"Estrogen therapy in postmenopausal women: effects on cognitive function and dementia.","volume":"279","author":"Yaffe","year":"1998","journal-title":"JAMA"},{"key":"R30-16-20210211","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4522(00)00410-3","article-title":"The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.","volume":"101","author":"Hogervorst","year":"2000","journal-title":"Neuroscience"},{"key":"R31-16-20210211","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.285.11.1489","article-title":"Hormone replacement therapy and cognition: systematic review and meta-analysis.","volume":"285","author":"LeBlanc","year":"2001","journal-title":"JAMA"},{"key":"R32-16-20210211","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy: scientific review.","volume":"288","author":"Nelson","year":"2002","journal-title":"JAMA"},{"key":"R33-16-20210211","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.54.11.2061","article-title":"Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.","volume":"54","author":"Wang","year":"2000","journal-title":"Neurology"},{"key":"R34-16-20210211","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","article-title":"Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimers Disease Cooperative Study.","volume":"283","author":"Mulnard","year":"2000","journal-title":"JAMA"},{"key":"R35-16-20210211","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1212\/WNL.54.2.295","article-title":"Estrogen for Alzheimers disease in women: randomized, double-blind, placebo-controlled trial.","volume":"54","author":"Henderson","year":"2000","journal-title":"Neurology"},{"key":"R36-16-20210211","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1212\/WNL.50.4.1141","article-title":"Postmenopausal estrogen use and Parkinsons disease with and without dementia.","volume":"50","author":"Marder","year":"1998","journal-title":"Neurology"},{"key":"R37-16-20210211","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","article-title":"Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.","volume":"277","author":"Snowdon","year":"1997","journal-title":"JAMA"},{"key":"R38-16-20210211","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effect of estrogen plus progestin on stroke in postmenopausal women: the Womens Health Initiative: a randomized trial.","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"key":"R39-16-20210211","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/01.wnl.0000339036.88842.9e","article-title":"Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study.","volume":"72","author":"Coker","year":"2009","journal-title":"Neurology"},{"key":"R40-16-20210211","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1212\/01.wnl.0000339037.76336.cf","article-title":"Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.","volume":"72","author":"Resnick","year":"2009","journal-title":"Neurology"},{"key":"R41-16-20210211","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/gerona\/glp128","article-title":"Brain volumes, cognitive impairment, and conjugated equine estrogens.","volume":"64","author":"Espeland","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R42-16-20210211","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ana.22239","article-title":"Timing of hormone therapy and dementia: the critical window theory revisited.","volume":"69","author":"Whitmer","year":"2011","journal-title":"Ann Neurol"},{"key":"R43-16-20210211","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2217\/17455057.3.2.173","article-title":"Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women.","volume":"3","author":"Yesufu","year":"2007","journal-title":"Womens Health (Lond)"},{"key":"R44-16-20210211","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archneur.1995.00540290075020","article-title":"The preclinical phase of probable Alzheimers disease. A 13-year prospective study of the Framingham cohort.","volume":"52","author":"Linn","year":"1995","journal-title":"Arch Neurol"},{"key":"R45-16-20210211","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1212\/01.WNL.0000163773.21794.0B","article-title":"Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years.","volume":"64","author":"Tierney","year":"2005","journal-title":"Neurology"},{"key":"R46-16-20210211","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archneur.64.6.862","article-title":"Neuropsychological measures in normal individuals that predict subsequent cognitive decline.","volume":"64","author":"Blacker","year":"2007","journal-title":"Arch Neurol"},{"key":"R47-16-20210211","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/1097-4679(198811)44:6<907::AID-JCLP2270440610>3.0.CO;2-8","article-title":"Sex differences in verbal learning.","volume":"44","author":"Kramer","year":"1988","journal-title":"J Clin Psychol"},{"key":"R48-16-20210211","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1037\/0894-4105.11.4.577","article-title":"Developmental sex differences in verbal learning.","volume":"11","author":"Kramer","year":"1997","journal-title":"Neuropsychology"},{"key":"R49-16-20210211","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/WNL.0b013e3181a71193","article-title":"Effects of the menopause transition and hormone use on cognitive performance in midlife women.","volume":"72","author":"Greendale","year":"2009","journal-title":"Neurology"},{"key":"R50-16-20210211","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/gme.0b013e31827655e5","article-title":"Cognition in perimenopause: the effect of transition stage.","volume":"20","author":"Weber","year":"2013","journal-title":"Menopause"},{"key":"R51-16-20210211","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1191\/1740774504cn040oa","article-title":"The Womens Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.","volume":"1","author":"Resnick","year":"2004","journal-title":"Clin Trials"},{"key":"R52-16-20210211","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2005-2097","article-title":"Effects of combination estrogen plus progestin hormone treatment on cognition and affect.","volume":"91","author":"Resnick","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R53-16-20210211","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1210\/jc.2009-1340","article-title":"Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy.","volume":"94","author":"Resnick","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-16-20210211","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1212\/01.WNL.0000132522.13574.67","article-title":"Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.","volume":"63","author":"Kang","year":"2004","journal-title":"Neurology"},{"key":"R55-16-20210211","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1212\/WNL.0b013e3181c34b0c","article-title":"Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study.","volume":"73","author":"Ryan","year":"2009","journal-title":"Neurology"},{"key":"R56-16-20210211","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/13697130903370316","article-title":"Postmenopausal hormone therapy and cognition: effects of timing and treatment type.","volume":"13","author":"Khoo","year":"2010","journal-title":"Climacteric"},{"key":"R57-16-20210211","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neurobiolaging.2010.10.007","article-title":"Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline.","volume":"33","author":"Kang","year":"2012","journal-title":"Neurobiol Aging"},{"key":"R58-16-20210211","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.gme.0000191204.38664.61","article-title":"Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study.","volume":"13","author":"MacLennan","year":"2006","journal-title":"Menopause"},{"key":"R59-16-20210211","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1196\/annals.1347.012","article-title":"A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use.","volume":"1052","author":"Maki","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R60-16-20210211","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0029-1216278","article-title":"Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies.","volume":"27","author":"Maki","year":"2009","journal-title":"Semin Reprod Med"},{"key":"R61-16-20210211","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1185\/03007997609109322","article-title":"Replacement therapy and piperazine oestrone sulphate (Harmogen) and its effect on memory.","volume":"4","author":"Hackman","year":"1976","journal-title":"Curr Med Res Opin"},{"key":"R62-16-20210211","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0306-4530(88)90060-1","article-title":"Estrogen andor androgen replacement therapy and cognitive functioning in surgically menopausal women.","volume":"13","author":"Sherwin","year":"1988","journal-title":"Psychoneuroendocrinology"},{"key":"R63-16-20210211","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0306-4530(92)90007-T","article-title":"Effects of estrogen on memory function in surgically menopausal women.","volume":"17","author":"Phillips","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"R64-16-20210211","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.GME.0000060241.02837.29","article-title":"Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen.","volume":"10","author":"Shaywitz","year":"2003","journal-title":"Menopause"},{"key":"R65-16-20210211","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psyneuen.2004.09.002","article-title":"Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women.","volume":"30","author":"Dunkin","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"R66-16-20210211","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.gme.0000230347.28616.1c","article-title":"Hot flashes and estrogen therapy do not influence cognition in early menopausal women.","volume":"14","author":"LeBlanc","year":"2007","journal-title":"Menopause"},{"key":"R67-16-20210211","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.gme.0000189618.48774.7b","article-title":"Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.","volume":"13","author":"Joffe","year":"2006","journal-title":"Menopause"},{"key":"R68-16-20210211","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"key":"R69-16-20210211","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0306-4530(99)00025-6","article-title":"Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels.","volume":"24","author":"Wolf","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"R70-16-20210211","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archneur.63.7.945","article-title":"Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.","volume":"63","author":"Yaffe","year":"2006","journal-title":"Arch Neurol"},{"key":"R71-16-20210211","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neurobiolaging.2004.12.012","article-title":"A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.","volume":"27","author":"Almeida","year":"2006","journal-title":"Neurobiol Aging"},{"key":"R72-16-20210211","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1532-5415.2007.01085.x","article-title":"The effect of 3-year treatment with 0.25 mgday of micronized 17-estradiol on cognitive function in older postmenopausal women.","volume":"55","author":"Pefanco","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"R73-16-20210211","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.psyneuen.2004.08.007","article-title":"Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study.","volume":"30","author":"Schiff","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"R74-16-20210211","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0406-379b","article-title":"Reply to Hormone in the hot seat.","volume":"12","author":"Toran-Allerand","year":"2006","journal-title":"Nat Med"},{"key":"R75-16-20210211","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1523\/JNEUROSCI.23-13-05708.2003","article-title":"Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys.","volume":"23","author":"Rapp","year":"2003","journal-title":"J Neurosci"},{"key":"R76-16-20210211","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1881-12.2012","article-title":"Clinically relevant hormone treatments fail to induce spinogenesis in prefrontal cortex of aged female rhesus monkeys.","volume":"32","author":"Ohm","year":"2012","journal-title":"J Neurosci"},{"key":"R77-16-20210211","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/cercor\/bhg121","article-title":"Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys.","volume":"14","author":"Tang","year":"2004","journal-title":"Cereb Cortex"},{"key":"R78-16-20210211","first-page":"238","article-title":"Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.","volume":"51","author":"Linzmayer","year":"2001","journal-title":"Arzneimittelforschung"},{"key":"R79-16-20210211","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neurobiolaging.2004.09.012","article-title":"Estradiol or estradiolprogesterone treatment in older women: no strong effects on cognition.","volume":"26","author":"Wolf","year":"2005","journal-title":"Neurobiol Aging"},{"key":"R80-16-20210211","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/01.wnl.0000277275.42504.93","article-title":"Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.","volume":"69","author":"Maki","year":"2007","journal-title":"Neurology"},{"key":"R81-16-20210211","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/gme.0b013e3181ace484","article-title":"Effects of botanicals and combined hormone therapy on cognition in postmenopausal women.","volume":"16","author":"Maki","year":"2009","journal-title":"Menopause"},{"key":"R82-16-20210211","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1447-0756.2010.01214.x","article-title":"Estrogen progestin therapy and cognition: a randomized placebo-controlled double-blind study.","volume":"36","author":"Alhola","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"R83-16-20210211","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5122(00)00214-0","article-title":"Effects of hormone replacement therapy on cognitive performance in elderly women.","volume":"38","author":"Binder","year":"2001","journal-title":"Maturitas"},{"key":"R84-16-20210211","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9343(02)01270-6","article-title":"Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogenprogestin Replacement Study.","volume":"113","author":"Grady","year":"2002","journal-title":"Am J Med"},{"key":"R85-16-20210211","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.psyneuen.2009.02.009","article-title":"A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women.","volume":"34","author":"Tierney","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"R86-16-20210211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/hbeh.1998.1476","article-title":"Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance.","volume":"34","author":"Resnick","year":"1998","journal-title":"Horm Behav"},{"key":"R87-16-20210211","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0197-4580(00)00123-8","article-title":"Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition.","volume":"21","author":"Maki","year":"2000","journal-title":"Neurobiol Aging"},{"key":"R88-16-20210211","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","article-title":"Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.","volume":"64","author":"Mosconi","year":"2005","journal-title":"Neurology"},{"key":"R89-16-20210211","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.281.13.1197","article-title":"Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.","volume":"281","author":"Shaywitz","year":"1999","journal-title":"JAMA"},{"key":"R90-16-20210211","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/gme.0b013e3181cc49e9","article-title":"Early menopausal hormone use influences brain regions used for visual working memory.","volume":"17","author":"Berent-Spillson","year":"2010","journal-title":"Menopause"},{"key":"R91-16-20210211","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brainres.2010.11.030","article-title":"Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life.","volume":"1379","author":"Maki","year":"2011","journal-title":"Brain Res"},{"key":"R92-16-20210211","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.psyneuen.2007.09.009","article-title":"Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women.","volume":"32","author":"Craig","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"R93-16-20210211","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.psyneuen.2008.08.006","article-title":"Reversibility of the effects of acute ovarian hormone suppression on verbal memory and prefrontal function in pre-menopausal women.","volume":"33","author":"Craig","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"R94-16-20210211","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0197-4580(02)00056-8","article-title":"Preliminary evidence that estrogen protects against age-related hippocampal atrophy.","volume":"24","author":"Eberling","year":"2003","journal-title":"Neurobiol Aging"},{"key":"R95-16-20210211","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1037\/a0017292","article-title":"A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women: evidence for a limited window of opportunity.","volume":"24","author":"Erickson","year":"2010","journal-title":"Neuropsychology"},{"key":"R96-16-20210211","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neurobiolaging.2006.09.001","article-title":"Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect.","volume":"29","author":"Lord","year":"2008","journal-title":"Neurobiol Aging"},{"key":"R97-16-20210211","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1196\/annals.1347.005","article-title":"Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.","volume":"1052","author":"Brinton","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R98-16-20210211","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women: Womens Health Initiative Memory Study.","volume":"291","author":"Espeland","year":"2004","journal-title":"JAMA"},{"key":"R99-16-20210211","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.162.4.683","article-title":"Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.","volume":"162","author":"Yaffe","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R100-16-20210211","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/GME.0b013e3182843aad","article-title":"Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future.","volume":"20","author":"Clarkson","year":"2013","journal-title":"Menopause"},{"key":"R101-16-20210211","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.","volume":"21","author":"Salpeter","year":"2006","journal-title":"J Gen Intern Med"},{"key":"R102-16-20210211","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"key":"R103-16-20210211","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.","volume":"137","author":"Kivipelto","year":"2002","journal-title":"Ann Intern Med"},{"key":"R104-16-20210211","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch Neurol"},{"key":"R105-16-20210211","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life.","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"R106-16-20210211","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimers disease in later life: longitudinal, population based study.","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"R107-16-20210211","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000231980","article-title":"Midlife serum cholesterol and increased risk of Alzheimers and vascular dementia three decades later.","volume":"28","author":"Solomon","year":"2009","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GME.0b013e3182960cf8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T22:42:27Z","timestamp":1653259347000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201306000-00016"}},"subtitle":["a scientific update on clinical studies"],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3182960cf8","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}